| 摘要 |
A compound for the manufacturing of a medicament for reducing or preventing mesothelial cell damage is described. The compound comprises a mixture of a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N2O) and can be used for prevention of adhesion formation, pain reduction, reducing or preventing acute inflammation, reducing or preventing CO2 resorbtion or reducing tumor cell implantation upon surgery. The compound may comprise for example between 1 and 29 volume percentage nitrous oxide gas, preferably between 5 and 20 volume percentage nitrous oxide gas, more preferably between 5 and 10 volume percentage nitrous oxide gas. The invention also relates to such a compound for the manufacturing of a medicament for preventing adhesion formation, to the use of such a compound in surgery for preventing adhesion formation, to a system and controller for supplying or using such a compound and to a corresponding method. |
